Page last updated: 2024-10-20

trimethyloxamine and Cancer of Pancreas

trimethyloxamine has been researched along with Cancer of Pancreas in 3 studies

trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.

Research Excerpts

ExcerptRelevanceReference
"Pancreatic cancer is a malignant tumor with the worst prognosis among all cancers."1.37Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. ( Chen, Z; Huang, H; OuYang, D; Xu, J, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Mirji, G1
Worth, A1
Bhat, SA1
El Sayed, M1
Kannan, T1
Goldman, AR1
Tang, HY1
Liu, Q1
Auslander, N1
Dang, CV1
Abdel-Mohsen, M1
Kossenkov, A1
Stanger, BZ1
Shinde, RS1
Huang, JY1
Luu, HN1
Butler, LM1
Midttun, Ø1
Ulvik, A1
Wang, R1
Jin, A1
Gao, YT1
Tan, Y1
Ueland, PM1
Koh, WP1
Yuan, JM1
OuYang, D1
Xu, J1
Huang, H1
Chen, Z1

Other Studies

3 other studies available for trimethyloxamine and Cancer of Pancreas

ArticleYear
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
    Science immunology, 2022, 09-09, Volume: 7, Issue:75

    Topics: Animals; Gastrointestinal Microbiome; Immune Checkpoint Inhibitors; Methylamines; Mice; Pancreatic N

2022
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
    Science immunology, 2022, 09-09, Volume: 7, Issue:75

    Topics: Animals; Gastrointestinal Microbiome; Immune Checkpoint Inhibitors; Methylamines; Mice; Pancreatic N

2022
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
    Science immunology, 2022, 09-09, Volume: 7, Issue:75

    Topics: Animals; Gastrointestinal Microbiome; Immune Checkpoint Inhibitors; Methylamines; Mice; Pancreatic N

2022
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
    Science immunology, 2022, 09-09, Volume: 7, Issue:75

    Topics: Animals; Gastrointestinal Microbiome; Immune Checkpoint Inhibitors; Methylamines; Mice; Pancreatic N

2022
A prospective evaluation of serum methionine-related metabolites in relation to pancreatic cancer risk in two prospective cohort studies.
    International journal of cancer, 2020, 10-01, Volume: 147, Issue:7

    Topics: Betaine; Case-Control Studies; Choline; Female; Humans; Male; Methionine; Methylamines; Middle Aged;

2020
Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis.
    Applied biochemistry and biotechnology, 2011, Volume: 165, Issue:1

    Topics: 3-Hydroxybutyric Acid; Aged; Female; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Met

2011